Roche Holding AG Company Profile (OTCMKTS:RHHBY)

About Roche Holding AG

Roche Holding AG logoRoche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai. Its Diagnostics division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. It develops medicines for the disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its product portfolio consists of Pharmaceuticals, Solutions for Diagnostics and Products for Researchers. Its Pharmaceutical products include ACTEMRA and CellCept. Its Solutions for Diagnostics products include Accu-Chek Active System and Accu-Chek Aviva Nano System. The Company's Products for Researchers include Cedex HiRes and Genome Sequencer FLX System.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: RHHBY
  • CUSIP:
Key Metrics:
  • Previous Close: $30.79
  • 50 Day Moving Average: $31.84
  • 200 Day Moving Average: $31.74
  • Trailing P/E Ratio: 22.38
  • Foreward P/E Ratio: 12.78
  • P/E Growth: 1.95
  • Market Cap: $210.52B
  • Outstanding Shares: 6,817,301,000
  • Beta: 0.69
Additional Links:
Companies Related to Roche Holding AG:

Analyst Ratings

Consensus Ratings for Roche Holding AG (OTCMKTS:RHHBY) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $177.50

Analysts' Ratings History for Roche Holding AG (OTCMKTS:RHHBY)
Show:
DateFirmActionRatingPrice TargetDetails
5/13/2016Jefferies GroupReiterated RatingBuyView Rating Details
4/1/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
1/22/2016Piper Jaffray Cos.Initiated CoverageOverweightView Rating Details
10/20/2015Cowen and CompanyDowngradeOutperform -> Market Perform$42.00 -> $35.00View Rating Details
10/13/2015Credit Suisse Group AGReiterated RatingOutperform$320.00View Rating Details
7/20/2015Baader BankUpgradeBuyView Rating Details
6/25/2015HSBCInitiated CoverageBuyView Rating Details
5/22/2015Erste GroupInitiated CoverageBuyView Rating Details
3/13/2015Liberum CapitalDowngradeHoldView Rating Details
1/28/2015Bryan, Garnier & CoUpgradeBuyView Rating Details
11/25/2014BNP ParibasInitiated CoverageOutperformView Rating Details
11/13/2014Kepler Capital MarketsDowngradeHoldView Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Roche Holding AG (OTCMKTS:RHHBY)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Roche Holding AG (OTCMKTS:RHHBY)
Current Year EPS Consensus Estimate: $1.9 EPS
Next Year EPS Consensus Estimate: $2.41 EPS

Dividends

Dividend History for Roche Holding AG (OTCMKTS:RHHBY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roche Holding AG (OTCMKTS:RHHBY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Roche Holding AG (OTCMKTS:RHHBY)
DateHeadline
finance.yahoo.com logoFDA Advises Zika Test for All U.S. Blood: Will Hologic Gain? (OTCMKTS:RHHBY)
finance.yahoo.com - August 29 at 11:41 AM
News IconRoche Receives US FDA Emergency Use Authorization for Zika Test (OTCMKTS:RHHBY)
ih.advfn.com - August 29 at 11:41 AM
thestreet.com logoRoche (RHHBY) Stock Higher, FDA Gives Emergency Approval for Zika Test (OTCMKTS:RHHBY)
www.thestreet.com - August 29 at 11:41 AM
marketrealist.com logoWhat's the Sector Composition of the Fidelity Advisor Overseas Fund? - Market Realist (OTCMKTS:RHHBY)
marketrealist.com - August 27 at 6:21 PM
marketrealist.com logoWhat's the Sector Composition of the MFS International Growth Fund? - Market Realist (OTCMKTS:RHHBY)
marketrealist.com - August 27 at 6:21 PM
marketrealist.com logoLet's look at what has contributed to the fund's performance YTD in 2016. - Market Realist (OTCMKTS:RHHBY)
marketrealist.com - August 27 at 6:21 PM
marketrealist.com logoWhat's the Sector Composition of the FNGAX? - Market Realist (OTCMKTS:RHHBY)
marketrealist.com - August 26 at 6:48 PM
wsj.com logoGermany's Merck Builds Up Non-Drug Businesses - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - August 26 at 10:04 AM
News IconShares Fall as Health-Care Sector Loses Ground -- Update (OTCMKTS:RHHBY)
ih.advfn.com - August 25 at 12:13 PM
4-traders.com logoRoche : launches innovative Accu-Chek Guide blood glucose monitoring system, which makes every step of testing easy (OTCMKTS:RHHBY)
www.4-traders.com - August 23 at 7:13 PM
4-traders.com logoRoche : launches innovative Accu-Chek® Guide blood glucose monitoring system, that makes every step of testing easy (OTCMKTS:RHHBY)
www.4-traders.com - August 23 at 11:39 AM
finance.yahoo.com logoInnovative Diagnostic and Therapeutic Products Seen at Roche (OTCMKTS:RHHBY)
finance.yahoo.com - August 22 at 11:43 AM
zacks.com logoCerulean (CERU) Kidney Cancer Drug Disappoints in Phase II (OTCMKTS:RHHBY)
www.zacks.com - August 18 at 10:08 AM
finance.yahoo.com logoROCHE HOLDING LTD /FI Financials (OTCMKTS:RHHBY)
finance.yahoo.com - August 16 at 7:13 PM
marketrealist.com logoPomalyst Continues to Witness Strong Global Demand in 2016 - Market Realist (OTCMKTS:RHHBY)
marketrealist.com - August 16 at 10:26 AM
zacks.com logoEpizyme Doses First Patient in Phase II Mesothelioma Study (OTCMKTS:RHHBY)
www.zacks.com - August 15 at 9:18 AM
marketrealist.com logoHow Did Valeant’s Segments Perform in 2Q16? (OTCMKTS:RHHBY)
marketrealist.com - August 12 at 10:19 AM
wsj.com logoSamsung BioLogics Aims to Raise Up to $2.5 Billion From IPO - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - August 11 at 7:38 PM
finance.yahoo.com logoEpizyme (EPZM) Q2 Loss Lower than Expected, Costs to Rise (OTCMKTS:RHHBY)
finance.yahoo.com - August 9 at 10:22 AM
wsj.com logoBlood Banks Step Up Efforts Against Zika Contamination - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - August 4 at 7:35 PM
wsj.com logoBiogen Draws Takeover Interest from Rival Drugmakers - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - August 2 at 7:29 PM
finance.yahoo.com logoWill ImmunoGen (IMGN) Disappoint Again on Q4 Earnings? (OTCMKTS:RHHBY)
finance.yahoo.com - August 2 at 7:29 PM
finance.yahoo.com logoRoche introduces virtual reality theater at AACC 2016 Clinical Lab Expo to give lab professionals firsthand glimpse of connected lab of the future (OTCMKTS:RHHBY)
finance.yahoo.com - August 2 at 12:06 PM
finance.yahoo.com logoRoche launches new target enrichment systems for genetic and translational research (OTCMKTS:RHHBY)
finance.yahoo.com - August 2 at 12:06 PM
marketrealist.com logoStrong Growth for Soliris in 2Q16 (OTCMKTS:RHHBY)
marketrealist.com - August 1 at 11:08 AM
wsj.com logoExperimental Alzheimer's Drug Fails in Clinical Trial - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - July 29 at 10:08 AM
4-traders.com logoRoche : emicizumab continued to show promising safety and efficacy profile in long-term study in people with severe haemophilia A (OTCMKTS:RHHBY)
www.4-traders.com - July 28 at 10:22 AM
marketrealist.com logoA Look at Roche’s Potential Revenue Drivers (OTCMKTS:RHHBY)
marketrealist.com - July 26 at 9:05 AM
fool.com logoAn Investing Overview of the Multiple Sclerosis Market (OTCMKTS:RHHBY)
www.fool.com - July 26 at 8:21 AM
finance.yahoo.com logoRoche (RHHBY) Misses on Q2 Revenues, New Launches in Focus (OTCMKTS:RHHBY)
finance.yahoo.com - July 25 at 6:32 PM
marketrealist.com logoUnderstanding the Performance of Roche’s Key Drugs (OTCMKTS:RHHBY)
marketrealist.com - July 25 at 11:06 AM
marketrealist.com logoSales Performance Analysis of Roche’s Pharmaceuticals Division (OTCMKTS:RHHBY)
marketrealist.com - July 25 at 9:07 AM
marketrealist.com logoDissecting Roche’s Performance across Its Segments (OTCMKTS:RHHBY)
marketrealist.com - July 22 at 6:01 PM
marketrealist.com logoReasons behind Roche’s Better-than-Expected 2Q16 Performance (OTCMKTS:RHHBY)
marketrealist.com - July 22 at 6:01 PM
wsj.com logoAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - July 21 at 7:27 PM
wsj.com logoRoche Sales Rise on Cancer Drugs - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - July 21 at 7:27 PM
ft.com logo[$$] Roche says UK faces losing lead in medical research after Brexit (OTCMKTS:RHHBY)
ad.doubleclick.net - July 21 at 6:35 AM
finance.yahoo.com logoRoche CEO Confident Business Will Succeed Despite Turmoil (OTCMKTS:RHHBY)
finance.yahoo.com - July 21 at 4:38 AM
News IconAre Analysts Bearish Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) After Last Week? - Consumer Eagle (OTCMKTS:RHHBY)
www.consumereagle.com - July 19 at 8:06 AM
finance.yahoo.com logoRoche's Gazyva Fails in Phase III B-cell Lymphoma Study (OTCMKTS:RHHBY)
finance.yahoo.com - July 18 at 6:42 PM
4-traders.com logoRoche : provides update on phase III study of Gazyva/Gazyvaro in people with previously untreated diffuse large B-cell lymphoma (OTCMKTS:RHHBY)
www.4-traders.com - July 18 at 12:37 PM
bloomberg.com logoRoche Blood Cancer Medicine Fails to Show Major Improvement (OTCMKTS:RHHBY)
www.bloomberg.com - July 18 at 4:45 AM
marketrealist.com logoHow Much Upward Potential Does Roche Really Have? - Market Realist (OTCMKTS:RHHBY)
marketrealist.com - July 17 at 6:31 PM
marketrealist.com logoHow Much Upward Potential Does Roche Really Have? (OTCMKTS:RHHBY)
marketrealist.com - July 15 at 8:02 PM
finance.yahoo.com logoCoaguChek® PT/ INR devices for use at the point of care and for patient self-testing remain a safe and effective option for patients on anticoagulation therapy (OTCMKTS:RHHBY)
finance.yahoo.com - July 15 at 12:52 PM
seekingalpha.com logoCelgene's R&D, Part 1: Background And The Juno Story - Seeking Alpha (OTCMKTS:RHHBY)
seekingalpha.com - July 14 at 7:24 PM
nasdaq.com logoNovartis' Enbrel Biosimilar Gets FDA Panel Recommendation - Nasdaq (OTCMKTS:RHHBY)
www.nasdaq.com - July 14 at 7:24 PM
wsj.com logoCravath, Swaine & Moore Names Faiza Saeed as Presiding Partner - Wall Street Journal (OTCMKTS:RHHBY)
www.wsj.com - July 14 at 7:24 PM
seekingalpha.com logoCelgene's R&D, Part 1: Background, And The Juno Story (OTCMKTS:RHHBY)
seekingalpha.com - July 14 at 10:44 AM
zacks.com logoAmgen and Daiichi Sankyo Team Up for Biosimilars in Japan (OTCMKTS:RHHBY)
www.zacks.com - July 14 at 10:44 AM

Social

Roche Holding AG (OTCMKTS:RHHBY) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff